> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Abbott Recalls Ellipse Implantable Defibrillators
- URL: https://www.fdaweb.com/abbott-recalls-ellipse-implantable-defibrillators/
- Published: 2019-08-05T12:00:00.000Z
- Updated: 2026-09-15T01:41:56.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5144685

Abbott has recalled its Ellipse Implantable Cardioverter Defibrillators (ICDs) after electrical failures had been identified and determined to be due to a faulty manufacturing process causing some aluminum wires to be partially exposed. This makes them prone to electrical shorting of the capacitor, a [recall notice](https://www.fda.gov/medical-devices/medical-device-recalls/abbott-formerly-st-jude-medical-inc-recalls-ellipse-implantable-cardioverter-defibrillators-due?ref=fdaweb.com) says. If a short occurs, a patient may not be given necessary high voltage therapy. Abbott says it is not aware of any related adverse event reports.

The devices provide pacing for slow heart rhythms and electrical shock or pacing to stop dangerously fast heart rhythms. They are implanted under the skin in the upper chest area with connecting insulated wires (leads) that go into the heart. “A patient may need an implantable cardiac device if their heartbeat is too slow (bradycardia), too fast (tachycardia), or needs coordination to treat heart failure,” the notice says.